Massachusetts Financial Services’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-263,363
Closed -$753K 913
2024
Q3
$753K Sell
263,363
-6,378
-2% -$17.9K ﹤0.01% 806
2024
Q2
$755K Buy
269,741
+9,054
+3% +$24.3K ﹤0.01% 811
2024
Q1
$740K Sell
260,687
-575
-0.2% -$1.95K ﹤0.01% 799
2023
Q4
$1.07M Sell
261,262
-8,252
-3% -$23.1K ﹤0.01% 770
2023
Q3
$857K Sell
269,514
-10,328
-4% -$32.8K ﹤0.01% 778
2023
Q2
$929K Sell
279,842
-6,594
-2% -$19.5K ﹤0.01% 756
2023
Q1
$610K Sell
286,436
-8,099
-3% -$20K ﹤0.01% 798
2022
Q4
$792K Buy
294,535
+6,234
+2% +$18.2K ﹤0.01% 795
2022
Q3
$934K Sell
288,301
-2,627
-0.9% -$11.9K ﹤0.01% 786
2022
Q2
$1.42M Buy
290,928
+1,470
+0.5% +$9.05K ﹤0.01% 752
2022
Q1
$2.21M Buy
289,458
+38,496
+15% +$298K ﹤0.01% 745
2021
Q4
$2.32M Buy
250,962
+90,457
+56% +$961K ﹤0.01% 765
2021
Q3
$2.29M Buy
160,505
+25,622
+19% +$398K ﹤0.01% 771
2021
Q2
$2.24M Buy
134,883
+102,563
+317% +$1.91M ﹤0.01% 765
2021
Q1
$589K Buy
+32,320
New +$438K ﹤0.01% 873

Other funds holding ORGO

Massachusetts Financial Services's ORGO Position: Q4 2024 in Review

Massachusetts Financial Services sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 263,363 shares — an estimated $753K sold.

Massachusetts Financial Services first reported a position in ORGO in Q1 2021 and held it in 15 quarters. The position peaked at $2.32M in Q4 2021. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Massachusetts Financial Services reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 263,363 Organogenesis Holdings shares in Q4 2024, an estimated $753K.
  • Massachusetts Financial Services first reported a position in Organogenesis Holdings in Q1 2021 and held it in 15 quarters.
  • Massachusetts Financial Services's Organogenesis Holdings position peaked at $2.32M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.